MYD88 and breast cancer: Particularly in breast cancer, SP1-induced overexpression of lncRNA AGAP2-AS1 upregulates MyD88 expression and activates the NF-κB signaling pathway by binding to the transcriptional coactivator CBP, which promotes breast cancer growth and enhances trastuzumab resistance 96.